Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US1510201049
Ticker CELG
Company CELGENE
Currency $
Price
Aware Investor Index (AII) 0.0574
Recommendation SELL
P/E 122.30
ROE 13.93 %
Capitalization 100,835,776,000 $
Dividend Yield 0.00 %
P/S 10.89
AII Position 531
P/E Position 733
ROE Position 278
Capitalization Position 82
Dividend Yield Position 629
Sales 9,256,000,000 $
10-Year Average Earnings 824,515,000 $
Shares Outstanding 824,900,000
Equity 5,919,000,000 $
Dividend per Share 0 $
Industry Biotechnology
Country United States
CELGENE Investor Relations Web Site http://ir.celgene.com







Sales:

YEAR MONTH AMOUNT
2015 12 9,256,000,000.00 $
2014 12 7,670,400,000.00 $
2013 12 6,493,900,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 1,602,000,000.00 $
2014 12 1,999,900,000.00 $
2013 12 1,449,900,000.00 $
2012 12 1,456,180,000.00 $
2011 12 1,318,150,000.00 $
2010 12 880,512,000.00 $
2009 12 776,747,000.00 $
2008 12 -1,533,653,000.00 $
2007 12 226,433,000.00 $
2006 12 68,981,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 5,919,000,000.00 $
2014 12 6,524,800,000.00 $
2013 12 5,589,900,000.00 $
2012 12 5,694,467,000.00 $
2011 12 5,512,727,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 824,900,000
2014 12 836,000,000
2013 12 430,300,000
2012 12 440,796,000
2011 12 422,987,284

 












Bloomberg News for CELGENE:

Jul 26, 2017
U.S. Equities Steady as Investors Await Fed; Tech Shares Higher
Helmerich & Payne Inc (HP), PG&E Corp (PCG), Comcast Corp (CMCSA), BorgWarner Inc (BWA),Celgene Corp (CELG), Johnson Controls International plc (JCI), Xcel Energy Inc (XEL),L3 Technologies Inc (LLL), Boston...
Aug 4, 2010
Arbitrage Profit in U.S. Takeovers Pending on Aug. 4
08/25/10 ARG US APD US 63.50 65.30 -1.80 -2.76 77,416 Cash 08/13/10 ABII US CELG US 72.75 75.78 -3.03 -3.99 2,776 C&S 12/31/10 CASY US ATD/B CN 36.75 ...
Feb 10, 2012
Nasdaq Short Interest as of Jan. 31
642 5,536 CECE CECO ENVIRONMNTL 6,147 7,504 31,975 CELG CELGENE CORP 7,920,994 9,159,230 3,595,048 CELGZ CELGENE CORP-CVR...
Jan 21, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
15.30 19.39 -8.43 BAC BANK OF AMERICA 26.4 23 14.34 18.13 -11.57 CELG CELGENE CORP 26.2 22 56.37 71.14 -2.40 GME GAMESTOP CORP-A 25...
Jan 7, 2011
S&P 500 Stocks With Biggest Gap Between Market Price, Estimate
46.18 55.88 -2.48 JPM JPMORGAN CHASE 20.8 22 43.28 52.30 1.77 CELG CELGENE CORP 20.8 22 59.34 71.68 4.61 CSCO CISCO SYSTEMS 20...
Jun 13, 2005
Online Extra: The Next Wave
application must be reviewed within six months after it's filed. Revlimid Celgene (CELG ) Myelodysplastic syndrome (MDS), a malignant blood-cell disorder that causes anemia...
Nov 13, 2003
Dreyer's Grand and Salem Lead `Sky High Six': John Dorfman
20, 2002, through Tuesday, Nov. 11. Celgene and Dreyer'sThe biggest gainer was Celgene Corp. (CELG), up 57 percent. Also strong was Herman Miller Inc. (MLHR), up 30 percent, and AVX Corp. (AVX)...
Sep 16, 2003
Biotech Regains Its Strength
among the biotech issues he covers? He has 5-STARS (buy) rankings on Amgen (AMGN ), Celgene (CELG ), Genzyme (GENZ ), MedImmune (MEDI ), and Millennium Pharmaceuticals (MLNM...
Feb 7, 2005
Online Extra: Healthy Investment?
7.81 Abbott Laboratories (ABT) 7.51 Celgene (CELG) 7.15 Bristol-Myers Squibb (BMY) ...
Jul 28, 2011
Midmorning Positive EPS Surprises for U.S. Companies, July 28
8.5 0.49 4.1 Jun DRE DUKE REALTY CORP 0.29 0.29 0.0 0.28 3.6 Jun CELG* CELGENE CORP 0.89 0.69 29.0 0.86 3.5 Jun K* KELLOGG CO ...


Google News for CELGENE:

Investorplace.com (blog) - 1 day ago
Celgene's (CELG) Upgraded to Buy
Celgene Corp (NASDAQ:CELG) is one of the 783 companies in the GICS Health Care sector, and a member of the 344 company ...
StreetInsider.com - 21 hours ago
Celgene (CELG) PT Raised to $167 at BMO Capital on Positive ...
Celgene (CELG) PT Raised to $167 at BMO Capital on Positive Data from Phase STEPTONE Study of Ozanimod in Crohn's Disease.
StreetInsider.com - 1 day ago
Celgene (CELG) Says Results from Phase 2 Studies of Oral ...
Celgene Corporation (NASDAQ: CELG) today announced that phase 2 data of investigational compound ozanimod in Crohn's disease and ...
Seeking Alpha - 2 Oct 2017
Celgene Could Be A $200 Stock
Celgene is positioned to continue double digit growth beyond 2020 ... Since its spin-off from Celanese in 1986, Celgene (CELG) has built an ...
Investorplace.com - 10 Oct 2017
Celgene (CELG) Stock Upgraded to Buy from a Hold
Celgene Corp (NASDAQ:CELG) is ranked as a Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's ...
Investor's Business Daily - 1 day ago
Celgene Blood Cancer Treatment: Just The Tip Of Its Disruptive ...
Celgene (CELG), a pioneer and leading player in blood cancer treatment, has become a biotech juggernaut thanks largely to a drug that ...
NormanObserver.com - 1 hour ago
Ingalls & Snyder Has Trimmed Celgene (CELG) Position By ...
Ingalls & Snyder Llc decreased Celgene Corp (CELG) stake by 13.66% reported in 2017Q2 SEC filing. Ingalls & Snyder Llc sold 4,194 shares ...
Simply Wall St - 18 hours ago
What You Must Know About Celgene Corporation's (CELG ...
With a market capitalization of USD $106.76B, Celgene Corporation (NASDAQ:CELG) falls in the category of stocks popularly identified as ...
TopChronicle
Celgene Corp. (CELG) Is Losing Ground Following Downgrade
(RTTNews.com) - Morgan Stanley downgraded its rating on shares of Celgene Corp. ( CELG ) Thursday morning to "Underweight" from "Equal ...
Wolcott Daily
Celgene Is Not a Sell, Jim Cramer Rebuts Analysts' Call
Shares of Celgene (CELG - Get Report) are tumbling 5.5% Thursday, thanks in part to some analyst coverage by Morgan Stanley. Analysts ...


Back